<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">24398888</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>04</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-2385</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>29</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</Title>
                <ISOAbbreviation>Nephrol Dial Transplant</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.</ArticleTitle>
            <Pagination>
                <MedlinePgn>672-81</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/ndt/gft515</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this study was to determine among maintenance hemodialysis patients with echocardiographic left ventricular hypertrophy and hypertension whether in comparison with a Î²-blocker-based antihypertensive therapy, an angiotensin converting enzyme-inhibitor-based antihypertensive therapy causes a greater regression of left ventricular hypertrophy.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Subjects were randomly assigned to either open-label lisinopril (n = 100) or atenolol (n = 100) each administered three times per week after dialysis. Monthly monitored home blood pressure (BP) was controlled to &lt;140/90 mmHg with medications, dry weight adjustment and sodium restriction. The primary outcome was the change in left ventricular mass index (LVMI) from baseline to 12 months.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, 44-h ambulatory BP was similar in the atenolol (151.5/87.1 mmHg) and lisinopril groups, and improved similarly over time in both groups. However, monthly measured home BP was consistently higher in the lisinopril group despite the need for both a greater number of antihypertensive agents and a greater reduction in dry weight. An independent data safety monitoring board recommended termination because of cardiovascular safety. Serious cardiovascular events in the atenolol group occurred in 16 subjects, who had 20 events, and in the lisinopril group in 28 subjects, who had 43 events {incidence rate ratio (IRR) 2.36 [95% confidence interval (95% CI) 1.36-4.23, P = 0.001]}. Combined serious adverse events of myocardial infarction, stroke and hospitalization for heart failure or cardiovascular death in the atenolol group occurred in 10 subjects, who had 11 events and in the lisinopril group in 17 subjects, who had 23 events (IRR 2.29, P = 0.021). Hospitalizations for heart failure were worse in the lisinopril group (IRR 3.13, P = 0.021). All-cause hospitalizations were higher in the lisinopril group [IRR 1.61 (95% CI 1.18-2.19, P = 0.002)]. LVMI improved with time; no difference between drugs was noted.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among maintenance dialysis patients with hypertension and left ventricular hypertrophy, atenolol-based antihypertensive therapy may be superior to lisinopril-based therapy in preventing cardiovascular morbidity and all-cause hospitalizations. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases; ClinicalTrials.gov number: NCT00582114).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Agarwal</LastName>
                    <ForeName>Rajiv</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Indiana University School of Medicine and Richard L. Roudebush Veterans AdministrationMedical Center, Indianapolis, IN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sinha</LastName>
                    <ForeName>Arjun D</ForeName>
                    <Initials>AD</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pappas</LastName>
                    <ForeName>Maria K</ForeName>
                    <Initials>MK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abraham</LastName>
                    <ForeName>Terri N</ForeName>
                    <Initials>TN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tegegne</LastName>
                    <ForeName>Getachew G</ForeName>
                    <Initials>GG</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT00582114</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2R01-DK063020-10</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>01</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nephrol Dial Transplant</MedlineTA>
            <NlmUniqueID>8706402</NlmUniqueID>
            <ISSNLinking>0931-0509</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>50VV3VW0TI</RegistryNumber>
                <NameOfSubstance UI="D001262">Atenolol</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>E7199S1YWR</RegistryNumber>
                <NameOfSubstance UI="D017706">Lisinopril</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001262" MajorTopicYN="N">Atenolol</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057239" MajorTopicYN="N">Early Termination of Clinical Trials</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017379" MajorTopicYN="N">Hypertrophy, Left Ventricular</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017706" MajorTopicYN="N">Lisinopril</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName>
                <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">hemodialysis</Keyword>
            <Keyword MajorTopicYN="N">hypertension</Keyword>
            <Keyword MajorTopicYN="N">randomized trial</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>4</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24398888</ArticleId>
            <ArticleId IdType="pii">gft515</ArticleId>
            <ArticleId IdType="doi">10.1093/ndt/gft515</ArticleId>
            <ArticleId IdType="pmc">PMC3938300</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Hypertension. 1979 Mar-Apr;1(2):136-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">399939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Dial. 2004 Jul-Aug;17(4):265-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15250915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1992 Dec 31;327(27):1912-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1454086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1995 Jul 20;333(3):155-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7791817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1997 Jun;51(6):1863-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9186876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1998 Apr;53(4):1078-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9551420</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 1998 May;31(5):1088-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9576119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1999 Apr;55(4):1528-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10201019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2005 Apr;45(4):811-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15699452</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2006 Oct;70(7):1318-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16871247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2006 Oct;48(4):606-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16997057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2009 Mar;53(3):500-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19153263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 Mar 21;373(9668):1009-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19249092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2009 May;53(5):860-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19273737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2010 Sep;56(3):512-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20625076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2000 Dec;36(6):945-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11116105</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2001 Dec;38(6):1245-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11728957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2002 Mar 19;105(11):1354-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11901048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2002 Mar 23;359(9311):1004-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11937179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2003 May 7;41(9):1438-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12742278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 2003 Sep;115(4):291-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12967694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Cardiol. 1986 Feb 15;57(6):450-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2936235</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
